Disease Overview：Peyronie’s Disease（PD）
Peyronie’s disease is a fibrotic disorder of the tunica albuginea characterized by the formation of palpable, non-calcified plaques—often accompanied by penile curvature, pain during erection, and potential erectile dysfunction. Its etiology remains incompletely understood but is thought to involve aberrant wound healing following microtrauma, with genetic, inflammatory, and connective tissue factors contributing to collagen dysregulation. Prevalence estimates range from 0.5% to 13% in adult males, typically presenting between ages 40–70. Diagnosis relies on clinical evaluation—including history, physical examination, and dynamic ultrasound to assess plaque location, size, elasticity, and associated vascular integrity—while differential diagnosis excludes conditions such as congenital curvature or fibrosis secondary to trauma or infection. Early-stage management may include oral agents (e.g., vitamin E, pentoxifylline, or colchicine), intralesional injections (verapamil, interferon-α2b, or collagenase clostridium histolyticum), or traction therapy; advanced cases often require surgical correction (plication, grafting, or penile prosthesis implantation) when functional impairment or psychological distress significantly impacts quality of life.
China offers distinct advantages for Peyronie’s disease treatment: leading urology centers—particularly in Beijing, Shanghai, and Guangzhou—employ multidisciplinary teams with deep expertise in male sexual medicine and reconstructive urology. Advanced imaging (high-resolution penile Doppler ultrasound, 3D curvature mapping) and minimally invasive techniques—including ultrasound-guided intralesional injection protocols and robotic-assisted grafting—are widely available. Clinical outcomes align with international benchmarks: published case series report >85% patient satisfaction with curvature correction and symptom relief after tailored interventions. Crucially, costs are typically 40–60% lower than in the US or Western Europe, without compromising safety or efficacy—e.g., collagenase treatment cycles cost approximately USD $2,500–$4,000 in China versus $8,000–$12,000 abroad. As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with certified specialists, verifying hospital accreditation (JCI or equivalent), providing itemized, transparent pricing in advance, arranging visa support, accommodation, and post-treatment follow-up—all while ensuring continuity of care and cultural concordance.
Peyronie’s Disease: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Peyronie’s Disease (Penile Induration)
Non-Surgical / Conservative Management
*Indicated for early-phase disease (<12 months), mild curvature (<30°), stable plaque, and absence of erectile dysfunction.*
- •Oral Pharmacotherapy
- *Vitamin E + Tamoxifen (off-label)*: ¥260–¥410/month ($36–$57) - *Colchicine*: ¥90–¥150/month ($13–$21)
- •Intralesional Injections
- *Xiaflex® (collagenase clostridium histolyticum)*: Not approved in China; unavailable clinically
- •Extracorporeal Shockwave Therapy (ESWT)
- *Pre-treatment labs (CBC, coagulation panel, penile Doppler ultrasound)*: ¥680–¥920 ($95–$128)
Surgical / Interventional Options
*Indicated for stable disease (>12 months), curvature ≥40°, functional impairment, or refractory pain.*
- •Plaque Incision/Excision + Grafting
- Procedure cost: ¥28,000–¥42,000 ($3,900–$5,850) - Pre-op workup (ECG, chest X-ray, penile Doppler, uroflowmetry): ¥1,350–¥1,800 ($188–$250)
- •Nesbit Plication (Tunical Shortening)
- Procedure cost: ¥16,500–¥23,000 ($2,300–$3,200) - Pre-op workup: ¥1,350–¥1,800 ($188–$250)
- •Penile Prosthesis Implantation (with concurrent plaque correction)
- *Three-piece inflatable prosthesis*: ¥58,000–¥82,000 ($8,080–$11,420) - *Malleable rod prosthesis*: ¥22,000–¥31,000 ($3,060–$4,320) - Pre-op workup + psychological evaluation: ¥2,100–¥2,700 ($292–$376)
Special / Complex Condition Management
- •*Recurrent deformity post-surgery*: Revision grafting — ¥35,000–¥52,000 ($4,870–$7,240)
- •*Severe shortening (>3 cm) + calcified plaque*: Combined excision + dermal graft + lengthening technique — ¥45,000–¥68,000 ($6,270–$9,470)
- •*Neurogenic ED comorbidity (e.g., spinal cord injury)*: Prosthesis + intraoperative nerve-sparing techniques — add ¥8,500–¥12,000 ($1,180–$1,670)
Quick Selection Guide
- •<50 years, mild curvature, budget-conscious: Start with oral pentoxifylline + ESWT (total ~$1,200–$2,000 over 6 months)
- •50–65 years, stable 45° curvature, intact erection: Nesbit plication (total ~$3,500–$3,700 including pre-op)
- •>65 years, ED + 70° deformity, high comorbidity burden: Malleable prosthesis + plaque correction (total ~$7,500–$9,000)
- •Recurrent deformity after prior surgery: Revision grafting with acellular dermal matrix — reserve for tertiary urology centers (¥45,000+ base cost)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Peyronie’s Disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Peyronie’s Disease treatment with China top medical destinations:
